Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention

Detalles Bibliográficos
Autores principales: Mikol, Daniel D., Snellman, Josefin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734219/
https://www.ncbi.nlm.nih.gov/pubmed/31164079
http://dx.doi.org/10.1186/s10194-019-0994-z
_version_ 1783450106258784256
author Mikol, Daniel D.
Snellman, Josefin
author_facet Mikol, Daniel D.
Snellman, Josefin
author_sort Mikol, Daniel D.
collection PubMed
description
format Online
Article
Text
id pubmed-6734219
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-67342192019-09-12 Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention Mikol, Daniel D. Snellman, Josefin J Headache Pain Letter to the Editor Springer Milan 2019-06-04 /pmc/articles/PMC6734219/ /pubmed/31164079 http://dx.doi.org/10.1186/s10194-019-0994-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Letter to the Editor
Mikol, Daniel D.
Snellman, Josefin
Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention
title Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention
title_full Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention
title_fullStr Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention
title_full_unstemmed Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention
title_short Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention
title_sort letter to the editor: european headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734219/
https://www.ncbi.nlm.nih.gov/pubmed/31164079
http://dx.doi.org/10.1186/s10194-019-0994-z
work_keys_str_mv AT mikoldanield lettertotheeditoreuropeanheadachefederationguidelinesontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention
AT snellmanjosefin lettertotheeditoreuropeanheadachefederationguidelinesontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention

Ejemplares similares